NG

Neil Goldsmith

Director Director DIN 01255721
DIN 01255721 First appointment Feb 2005 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Feb 2005
Shareholding value Locked Premium profile

About Neil Goldsmith

Data last updated:

Neil Goldsmith has 21 years in corporate governance. Formerly with 1 company, such as Evolva Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 01255721
Primary Designation Director
First Appointment 07 Feb 2005
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Evolva Biotech Private Limited U24230TN2005PTC076643
Director07 Feb 20052005Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Evolva Biotech Private Limited
Premium access

Shareholding and investment profile for Neil Goldsmith

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neil Goldsmith

Neil Goldsmith has 21 years in corporate governance. Formerly with 1 company, such as Evolva Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Neil Goldsmith is associated with 0 companies as a director.

Neil Goldsmith has expertise in Technology.

Neil Goldsmith has 21 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available